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INTRODUCTION
Acute pancreatitis (AP) is a serious disease with high mortality (1). The reported incidence is variable in different countries (10-100/100,000 people) (2), and AP is a leading cause of acute hospitalization for gastrointestinal disorders (3). Therefore, large, nationwide, prospectively collected cohorts are needed. Adherence to treatment guidelines has been documented to reduce mortality and/or severity of AP (1). Inspite of the rising incidence of pediatirc pancreatitis in the past few years (4-11), international guideline for the management of childhood onset pancreatitis is still missing.
Therefore research on pancreatitis both in adult and pediatruc field are crucially important.
AIMS
Specific aim 1.
The main goals of our study were to analyse the course of AP in a prospectively collected cohort of patients from Hungarian centres and to validate the major recommendations in the IAP/APA evidence-based guidelines for the management of AP.
Specific aim 2.
To organize an international, observational clinical trial for pediatric pancreatitis to collect a critical mass of clinical data and biomedical research samples in uniform, prospective manner (Analysis of Pediatric Pancreatitis-APPLE).
Specific aim 3.
Identify potential pathogenic promoter variants of SPINK1 in CP patients, determine their possible linkage with SPINK1 coding region variants, and assess the relevance of the novel promoter variants in relation to disease. 
PATIENTS AND METHODS (P&M)
P&M for Aim 3: Variants in Chronic Pancreatitis
Nomenclature
Nucleotide numbering reflects coding DNA numbering with +1 corresponding to the A of the ATG translation initiation codon in the SPINK1 reference sequence (RefSeq:
NG_008356.1). Promoter variants were numbered relative to the first nucleotide 5′ of the ATG initiation codon, designated −1.
Patients
Patients were recruited through the Hungarian National Pancreas Registry (www.pancreas.hu). All patients enrolled were Hungarian and gave their informed consent according to the ethical guidelines of the Declaration of Helsinki. A total of 100 unrelated patients with CP (cases) and 100 subjects with no pancreatic disease (controls) were enrolled.
DNA Extraction
Whole blood was collected in EDTA tubes and stored at −80°C. Genomic DNA was extracted from peripheral blood leukocytes using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany).
Mutational Analysis
The p.N34S mutation was detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism. SPINK1 promoter variants were introduced into this construct by overlap extension PCR mutagenesis.
Dual Luciferase Reporter Gene Assay
Luciferase expression was measured using the Dual-Glo Luciferase Assay System (Promega). Relative luciferase activity was determined by dividing the firefly and renilla luciferase luminescence results and expressing this firefly/renilla ratio as the percentage of the wild-type pGL3-SPINK1 value. Results were obtained from 3 to 8 independent transfection experiments.
Statistical methods for studies 3.1-3
Several statistical models have been used to see association between the investigated variables (for details see doctoral thesis and the articles).
RESULTS
Pancreatitis in adults 4.1.1. Epidemiology and aetiology
In our cohort, 56% (n=335) of the patients were male, and 44% (n=265) were female.
AP incidence in the males increased between 33 and 38 years and remained high until 68 years, after which it sharply declined. In the females, the highest incidence was between 53 and 78 years. The majority (61.2%) of the cases were mild, 30% were moderate, and 8. The most common aetiology of AP was biliary disease (43.8%) and alcohol abuse (26.5%). Relative to other aetiologies, the frequency of hyperlipidaemia was significantly lower in mild AP, whereas it was higher in moderate and severe AP, indicating that hyperlipidaemia is a risk factor for severity.
Anamnestic data collected at admission revealed that 21.2% of AP was recurrent and 4.9% had a family history of AP. History of alcohol consumption or smoking was associated with higher mortality in severe AP.
Diagnosis, anamnestic data and symptoms at admission
The majority of AP patients usually presented at emergency departments 1-6 hours or 19-24 hours after the onset of abdominal pain. Not seeking medical attention during the first four days of AP strongly heightened the risk for severe AP and mortality.
In 44.9% of the cases, all three diagnostic criteria (abdominal pain, serum pancreatic enzyme elevation, imaging alterations) were present. Importantly, the lack of an increase in enzyme was a risk factor for severe pancreatitis, whereas the lack of abdominal pain demonstrated a risk for mortality. The absence of imaging alterations in the pancreas significantly decreased the risk of severe AP.
Physical examination at admission
Although a tendency for association was observed between the rise in BMI and severity of AP, a significant difference was not found. With regard to the physical examination, abdominal tenderness developed in all the patients suffering from severe AP; however, the lack of this symptom was favourable for mortality. Abdominal guarding developed in 6.4% of the patients during AP, and this symptom was associated with increased mortality in severe AP.
Systolic blood pressure above 180 Hgmm or elevation of heart rate above 100 was significantly connected with severe AP.
Imaging at admission
All the patients had either abdominal US or CT at admission. During abdominal US, only 74.3% of the investigators described the status of the lungs. Pleural fluid and/or pulmonary infiltrates were found in 6.7% of the US examinations, 26.6% of the X-rays and 75.6% of the CT scans. Importantly, mortality was not observed in the absence of lung injury at admission.
Laboratory parameters at admission
A white blood cell (WBC) count above 23,000/µL was associated with severe AP (OR 
Complications
The most common organ complication in severe AP was of pancreatic origin (87.5%), followed by lung (68.1%), cardiac (47.7%), kidney (36.4%) and brain (11.1%) injury. Mortality in severe AP without respiratory failure was 6.7%, whereas it increased to 50% if lung injury persisted for more than 24 hours. Mortality in severe AP with no cardiac failure was 8.7%, while it was elevated to 57.1% if cardiac failure lasted for more than 24 hours. Importantly, local complications during AP had no effect on the risk of mortality.
Conservative therapy
Statistical analyses of fluid resuscitation practices in the first 24 hours showed that both severity and mortality are affected by the amount of fluid administered. The optimal fluid amount was between 1500 and 3500 mL. Enteral feeding was employed in 28.7% of the patients. The majority (85.4%) of the patients with severe AP received enteral feeding. In severe AP, the mortality rate rose from 27% to 57% when enteral feeding was not administered.
The practice of antibiotic therapy was widespread in our cohort (77.1% of the cases). In two-thirds of the cases, the indication was for the prevention of infectious complications. There were no relevant differences in mortality or severity between patients who received antibiotics for prevention and those who were treated with antibiotics for infection.
Endoscopic therapy
In 80.6% of the patients with biliary aetiology, ERCP was performed. In 91.9% of the cases, the endoscopic intervention was carried out within the first 48 hours after the diagnosis of AP. In 33.1% of the patients, cholangitis was present, 81.3% had obstruction, and 35.3% had severe or moderate AP. Endoscopic biliary sphincterotomy was carried out in 71.8% of the cases, while endoscopic pancreatic sphincterotomy was conducted in only 7%. A biliary stent was placed in 11.2% of the cases, and 11.5% of the patients received a pancreatic stent.
Interventions
Interventions were performed in 26 cases (4.3%) in our cohort, of which 62% were surgical operations, 19% endoscopic procedures and 19% radiological interventions.
Pediatric pancreatitis
Our APPLE trial is currently running. Until now we have enrolled 75 acute, 32 recurrent acute and 14 chronic pancreatitis cases to the APPLE-R study: Concerning the etiology, biliary and drug-induced 9-9%, trauma, acohol2-2%, post-ERCP and anatomic 5-5%, other 14% were identified however 54% of the cases still remained idiopathic. 
SPINK1 Promoter Variants in Chronic Pancreatitis
Sequence Analysis of the SPINK1 Promoter Region
In the approximately 1.2-kb SPINK1 promoter region, 6 different variants were promoter variants was detected in controls.
Sequence Analysis of the SPINK1 Coding Region
The c. 
DISCUSSION
Our study in adults contain among the largest cohorts of any publication on prospectively collected clinical data in AP to date. With regard to epidemiology, our study confirmed findings from other cohorts showing that AP in women is more likely related to gallstones, alcohol-related pancreatitis is more common in men (13, 14) , and age is a risk factor for AP (15) . Cigarette smoking has been linked to AP (16, 17) ; we observed that smoking was connected with greater mortality in severe AP.
Hypertriglyceridaemia was an etiological factor of AP in our cohort, as described for other cohorts (18) (19) (20) (21) . A rise in a serum triglyceride level above 11.3 mmol/L in a patient with AP is considered diagnostic, whereas above 5.6 mmol/L considered suspicion for hypertriglyceridemia-induced AP (19) . In our study, an increase in serum triglycerides above 5.6 mmol/L was considered as causative whenever no other obvious aetiology of AP was apparent. One of the most important new observations of this study is that hypertriglyceridaemia is associated with severe AP. We could see a tendency between the rise in BMI and risk of severe AP.
With regard to laboratory parameters, a WBC count above 23,000/µL, CRP evels above 200 mg/L, PCT levels above 10 U/L, calcium levels below 2 mmol/L and triglyceride levels above 40 mmol/L were all associated with severe AP. Average glucose levels differed significantly between the three AP severity groups.
Our study support the recommendations in the IAP/APA guidelines. The first 24 hours were found to be the "golden hours" in AP (22, 23) . For example, recommendations D9-10 highlight the importance of fluid resuscitation at admission. In our cohort, fluid volume below 1500 mL or above 3500 mL raised the risk of mortality and AP severity. In the current study, 71.7% of the patients received the recommended amount of fluid. In this group, the severity rate was only 7.8%, whereas it increased to 14.1% in patients who were given less than 1500 mL or more than 3500 mL. Moreover, the mortality rate was also elevated from 2.3% to 5.1%.
If Secondly, we wanted to investigate the situation is children. Although the incidence of AP in children is only 2-3 times less than in adults, our knowledge in pediatric AP is very limited. The current situation is difficult for the following reasons: (i) there is a limited number of scientists working in the field, genetic tests for pancreatic patients are unavailable or testing is not organized at the national level in most of the countries, (ii) there is a big and unacceptable high difference in disease recognition and outcome among the countries, (iii) limited number of biobanks or patient registers are available; those that exist are mostly organized on national levels with no links to international consortia and (iv) funding is often refused because of the low importance. Therefore, multinational efforts are crucially needed (24) .
In summary, we propose a multinational observational clinical trial (APPLE) to collect a critical mass of clinical data from children suffering from AP in an uniform prospective manner to help fill the knowledge gap and provide simple, pediatric-specific, clinical scoring system that can stratify patients with AP on presentation. It is important to mention that after the APPLE study, we plan to design a follow-up longitudinal study for better understanding of PP.
Thirdly, In the present thesis we choose a gene which alterations can be found in both adult and children. Sequencing of the SPINK1 promoter region in a Hungarian cohort of CP patients revealed 6 different variants. Of these, the c.-807C>T variant was found in both cases and controls with comparable frequencies and could be considered as a common polymorphism with no clinical significance. The c.-253T>C variant occurred significantly more frequently in ICP patients than in controls; however, a similar enrichment was not observed in ACP patients.
We conducted functional characterization of this variant by luciferase reporter gene assay. This variant had no considerable effect on promoter activity, suggesting that c.-253T>C is a harmless variant. ▪Hyperlipidaemia is a risk factor for severity.
NEW DISCOVERIES
▪Lack of serum enzyme elevation posed a risk for severe AP.
▪Lack of abdominal pain at admission demonstrated a risk for mortality.
▪Deviation from the recommendations in the IAP/APA evidence-based guidelines on fluid replacement, enteral nutrition and timing of interventions increased severity and mortality.
Analysis of Pediatric Pancreatitis (APPLE Trial)
This is the first worldwide study on the field of childhood onset pancreatitis for earlier (APPLE-R) and ongoing episodes (APPLE-P) of pancreatitis to collect a critical mass of clinical data and biomedical research samples in uniform prospective manner.
SPINK1 Promoter Variants in Chronic Pancreatitis
The common SPINK1 promoter variant c.-253T>C was associated with CP in this cohort. Two of 3 newly identified SPINK1 promoter variants seem to exhibit significant functional defects and should be considered potential risk factors for CP. 
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